Comparison of proteomic profiles of serum, plasma, and modified media supplements used for cell culture and expansion.
about
A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers".Analysis of human synovial and bone marrow mesenchymal stem cells in relation to heat-inactivation of autologous and fetal bovine serums.Measuring carbonic anhydrase IX as a hypoxia biomarker: differences in concentrations in serum and plasma using a commercial enzyme-linked immunosorbent assay due to influences of metal ions.Do Matrix Metalloproteases and Tissue Inhibitors of Metalloproteases in Tenocytes of the Rotator Cuff Differ with Varying Donor Characteristics?Enumeration of the colony-forming units-fibroblast from mouse and human bone marrow in normal and pathological conditions.Suppression of nanoparticle cytotoxicity approaching in vivo serum concentrations: limitations of in vitro testing for nanosafety.Plasma contributes to the antimicrobial activity of whole blood against Mycobacterium tuberculosis.Effects of human serum and apo-Transferrin on Staphylococcus epidermidis RP62A biofilm formation.Fetal calf serum heat inactivation and lipopolysaccharide contamination influence the human T lymphoblast proteome and phosphoproteome.Autologous serum improves yield and metabolic capacity of monocyte-derived hepatocyte-like cells: possible implication for cell transplantation.Protection of bovine chondrocyte phenotype by heat inactivation of allogeneic serum in monolayer expansion cultures.Culture Medium Supplements Derived from Human Platelet and Plasma: Cell Commitment and Proliferation Support.Contribution of Streptococcus mutans Strains with Collagen-Binding Proteins in the Presence of Serum to the Pathogenesis of Infective Endocarditis.Effect of anticoagulants on the protein corona-induced reduced drug carrier adhesion efficiency in human blood flow.FIV vaccine with receptor epitopes results in neutralizing antibodies but does not confer resistance to challenge.
P2860
Q30440347-63F90E39-777C-4E0F-8824-6561218B614BQ33692373-81DB335A-E0CB-4F6B-937E-73E2D840783DQ35015917-962C0227-38FD-4545-83B6-CF698C4265CBQ35813981-4D02CD07-4BAE-49D5-B872-D62D6B3FA369Q37367098-C5BCCFBA-1347-4FC4-A25E-27D24AF92438Q38945597-83C9A111-0F8B-4161-B89D-BE6808440947Q40565501-9824DA9E-6A94-4CDA-87AE-ACADF4734611Q40672416-D2F49432-736F-4B2A-BB58-11BB4404590BQ41186947-FB560D29-002B-457A-9AB3-38B610108119Q45812153-81765D0D-0296-4946-AD28-51BBD0FEAE94Q46810042-14C7E0C8-0834-4CC1-89B9-FA890391DE75Q47146088-FBC97858-7658-4338-9D5D-EBD313FEAB0BQ47744194-9E62F0C5-E81A-474B-9A0B-867E1243A8F8Q49641882-49C9CCCB-DD52-49CD-BC89-5F7A25A26094Q53686365-30BE0258-AB34-431E-A42D-7A1E1F7B6B4C
P2860
Comparison of proteomic profiles of serum, plasma, and modified media supplements used for cell culture and expansion.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Comparison of proteomic profil ...... or cell culture and expansion.
@ast
Comparison of proteomic profil ...... or cell culture and expansion.
@en
type
label
Comparison of proteomic profil ...... or cell culture and expansion.
@ast
Comparison of proteomic profil ...... or cell culture and expansion.
@en
prefLabel
Comparison of proteomic profil ...... or cell culture and expansion.
@ast
Comparison of proteomic profil ...... or cell culture and expansion.
@en
P2093
P2860
P356
P1476
Comparison of proteomic profil ...... or cell culture and expansion.
@en
P2093
David F Stroncek
Francesco M Marincola
Karen M Byrne
Monica C Panelli
Saleh Ayache
Stefanie Slezak
Susan F Leitman
P2860
P2888
P356
10.1186/1479-5876-4-40
P577
2006-10-04T00:00:00Z
P5875
P6179
1020876029